Dr. Weizman’s academic appointment is as Clinician in Quality and Innovation. His research interests include healthcare quality and health outcomes, with a focus on inflammatory bowel disease (IBD). Dr. Weizman is involved in teaching at the graduate, undergraduate, and post-graduate levels.
In some individuals, poor prognostic factors are present that may indicate a more severe disease course, such as need for hospitalization and surgery.
The symptoms of UC vary by person and range from mild, with long periods between flare-up of symptoms (called remission), to severe symptoms that can result ...